Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:39:54.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Mucosa-associated lymphoma and B-cell chronic lymphocytic leukemia to the list of diseases relevant to the study.
    Difference
    0.1%
    Check dated 2026-03-28T03:26:17.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:01:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:50.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1, replacing the previous v3.4.0 label on the page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.